Bloomberg Business News reports today that:
“Merck & Co. officials hid the risks that its Fosamax osteoporosis drug could weaken bones and lead to femur fractures, a lawyer told an Atlantic City jury in the first case raising such claims to come to trial.”
The report continues:
“To protect Fosamax sales, Merck officials for 15 years ignored studies and side-effect reports indicating that long- term Fosamax use put women taking it to prevent osteoporosis at risk for ‘atypical femur fractures.’”
Sound familiar?
How on earth Merck manages to stay in business is beyond me. They are a menace to society, far more perilous than a pack of stinking-drunk airline pilots.
The full story here: